The prevalence of neuropathy among type 1 diabetic adolescents in Iran: a systematic review and meta-analysis

References

[1] Mohammadi M, Raiegan V, Akbar A, Mirzaei M, Zahednezhad H, Jalali R, et al. Prevalence of underweight in Iranian children: a systematic review and meta-analysis. Tehran Univ Med J. 2018;76(4):241–9.Suche in Google Scholar

[2] Moţăţăianu A, Maier S, Bajko Z, Voidazan S, Bălaşa R, Stoian A. Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients. BMC Neurol. 2018;18(1):126.10.1186/s12883-018-1125-1Suche in Google Scholar PubMed PubMed Central

[3] Shohani M, Tavan H. Arbitrary use of insulin and its consequence. Iran J Public Health. 2018;47(8):1226–7.Suche in Google Scholar

[4] Cheraghi F, Mortazavi S, Shamsaei F, Moghimbeigi A. Effect of education on management of blood glucose in children with diabetes. J Nurs Educ. 2014;3(1):1–11.Suche in Google Scholar

[5] Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461.10.1038/s41598-017-13379-zSuche in Google Scholar PubMed PubMed Central

[6] Papatheodorou K, Banach M, Edmonds M, Papanas N, Papazoglou D. Complications of diabetes. J Diabetes Res. 2015;2015. DOI: 10.1155/2015/189525.Suche in Google Scholar PubMed PubMed Central

[7] De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.10.1097/00006842-200107000-00015Suche in Google Scholar PubMed

[8] Robinson MÈ, Altenor K, Carpenter C, Bonnell R, Jean‐Baptiste E, von Oettingen J. High rates of ocular complications in a cohort of Haitian children and adolescents with diabetes. Pediatr Diabetes. 2018;19(6):1124–1130. DOI: 10.1111/pedi.12688.Suche in Google Scholar PubMed

[9] Feldman MA, Anderson LM, Shapiro JB, Jedraszko AM, Evans M, Weil LE, et al. Family-based interventions targeting improvements in health and family outcomes of children and adolescents with type 1 diabetes: a systematic review. Curr Diab Rep. 2018;18(3):15.10.1007/s11892-018-0981-9Suche in Google Scholar PubMed

[10] Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455–68.10.2147/TCRM.S131945Suche in Google Scholar PubMed PubMed Central

[11] Amraei M, Mohamadpour S, Sayehmiri K, Mousavi SF, Shirzadpour E, Moayeri A. Effects of vitamin D deficiency on incidence risk of gestational diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2018;9:7.10.3389/fendo.2018.00007Suche in Google Scholar PubMed PubMed Central

[12] Mutlu EK, Unver B, Taskiran H, Ozgen IT. An investigation of the foot ankle joint mobility, muscle strength, and foot structure in adolescent with type 1 diabetes. Int J Diabetes Dev Ctries. 2018;38(1):108–14.10.1007/s13410-017-0556-3Suche in Google Scholar

[13] Elbarbary NS, Ismail EAR, El‐Naggar AR, Hamouda MH, El‐Hamamsy M. The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo‐controlled trial. Pediatr Diabetes. 2018;19(3):470–7.10.1111/pedi.12564Suche in Google Scholar PubMed

[14] Peng S, Li C, Sun X. Complications of diabetes diagnosed in children and adolescents. J Am Med Assoc. 2017;317(24):2552–3.10.1001/jama.2017.6223Suche in Google Scholar PubMed

[15] Olfatifar M, Karami M, Shokri P, Hosseini SM. Prevalence of chronic complications and related risk factors of diabetes in patients referred to the diabetes center of Hamedan Province. Sci J Hamadan Nurs Midwifery Fac. 2017;25(2):69–74.10.21859/nmj-25029Suche in Google Scholar

[16] Alvarado-Martel D, Velasco R, Sánchez-Hernández RM, Carrillo A, Nóvoa FJ, Wägner AM. Quality of life and type 1 diabetes: a study assessing patients’ perceptions and self-management needs. Patient Prefer Adherence. 2015;9:1315–23.10.2147/PPA.S87310Suche in Google Scholar PubMed PubMed Central

[17] Stahl-Pehe A, Lange K, Bächle C, Castillo K, Holl RW, Rosenbauer J. Mental health problems among adolescents with early-onset and long-duration type 1 diabetes and their association with quality of life: a population-based survey. PLoS One. 2014;9(3):e92473.10.1371/journal.pone.0092473Suche in Google Scholar PubMed PubMed Central

[18] Castellano-Guerrero A, Guerrero R, Relimpio F, Losada F, Mangas M, Pumar A, et al. Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting. Acta Diabetol. 2018;55:943–53.10.1007/s00592-018-1172-5Suche in Google Scholar PubMed

[19] Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5(2):112–9.10.2174/157339909788166828Suche in Google Scholar PubMed PubMed Central

[20] Trotta D, Verrotti A, Salladini C, Chiarelli F. Diabetic neuropathy in children and adolescents. Pediatr Diabetes. 2004;5(1):44–57.10.1111/j.1399-543X.2004.00041.xSuche in Google Scholar PubMed

[21] Salvotelli L, Stoico V, Perrone F, Cacciatori V, Negri C, Brangani C, et al. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: the Verona Diabetic Foot Screening Program. J Diabetes Complications. 2015;29(8):1066–70.10.1016/j.jdiacomp.2015.06.014Suche in Google Scholar PubMed

[22] Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, et al. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract. 2014;103(3):522–9.10.1016/j.diabres.2013.12.003Suche in Google Scholar PubMed

[23] Louraki M, Katsalouli M, Kanaka-Gantenbein C, Kafassi N, Critselis E, Kallinikou D, et al. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2). Diabetes Res Clin Pract. 2016;117:82–90.10.1016/j.diabres.2016.04.044Suche in Google Scholar PubMed

[24] Abbott CA, Malik RA, Ernest R, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetes population in the UK. Diabetes Care. 2011:34:2220–4.10.2337/dc11-1108Suche in Google Scholar PubMed PubMed Central

[25] Hasani N, Khosrawi S, Hashemipour M, Haghighatiyan M, Javdan Z, Taheri MH, et al. Prevalence and related risk-factors of peripheral neuropathy in children with insulin-dependent diabetes mellitus. J Res Med Sci. 2013;18(2):132–6.Suche in Google Scholar

[26] Ghaemi N, Hasanabadi H, Ashrafzadeh F, Sarvari S, Rahimi H, Hashemian S. Peripheral neuropathy in children and adolescents with insulin-dependent diabetes mellitus. Iran J Child Neurol. 2018;12(2):83–90.Suche in Google Scholar

[27] Sobhani S, Asayesh H, Sharifi F, Djalalinia S, Baradaran HR, Arzaghi SM, et al. Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis. J Diabetes Metab Disord. 2014;13(1):97.10.1186/s40200-014-0097-ySuche in Google Scholar PubMed PubMed Central

[28] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.10.7326/0003-4819-151-4-200908180-00135Suche in Google Scholar PubMed

[29] Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.10.1097/EDE.0b013e3181577654Suche in Google Scholar PubMed

[30] Karamifar H, Mooadab M, Karamizadeh Z, Amirhakimi G. Evaluation of peripheral neuropathy in patients with type 1 diabetes mellitus by bedside scoring procedure. Iran J Pediatr. 2007;17(Suppl 1):54–60.Suche in Google Scholar

[31] Khorasani E. Prevalence of peripheral neuropathy and its related factors in diabetic children, Neishabour city, Iran. Int J Pediatr. 2018;6(12):8707–14.Suche in Google Scholar

[32] Olfatifar M, Karami M, Hosseini SM, shokri P. Prevalence of chronic complications and related risk factors of diabetes in patients referred to the diabetes center of Hamedan Province. Sci J Hamadan Nurs Midwifery Fac. 2017;25(2):69–74.10.21859/nmj-25029Suche in Google Scholar

[33] Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch Iran Med. 2013;16(1):17–9.Suche in Google Scholar

[34] Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10(1):8.10.1186/s13098-018-0309-6Suche in Google Scholar PubMed PubMed Central

[35] Pop‐Busui R, Lu J, Lopes N, Jones TL. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst. 2009;14(1):1–13.10.1111/j.1529-8027.2009.00200.xSuche in Google Scholar PubMed PubMed Central

[36] Bai J-W, Lovblom LE, Cardinez M, Weisman A, Farooqi MA, Halpern EM, et al. Neuropathy and presence of emotional distress and depression in longstanding diabetes: results from the Canadian study of longevity in type 1 diabetes. J Diabetes Complications. 2017;31(8):1318–24.10.1016/j.jdiacomp.2017.05.002Suche in Google Scholar PubMed